Precision-GI™ FDA Designated Breakthrough product and FDA cleared semi-automated motorized endoscopic biopsy device entering U.S. market YOKNEAM, Israel, Nov. 7, 2024 /PRNewswire/ -- The Centers for Medicare & Medicaid Services (CMS) has granted transitional pass-through (TPT) payment for Limaca Medical Ltd. ("Limaca")'s Precision-GI™ motorized endoscopic biopsy device. Limaca's endoscopic device is designed to obtain improved biopsy results for patients with suspected gastrointestinal cancers such as pancr ...